Hyperfine, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US44916K1060
USD
1.60
0.21 (15.11%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
KORU Medical Systems, Inc.
Hyperfine, Inc.
Sight Sciences, Inc.
Inogen, Inc.
Xtant Medical Holdings, Inc.
Stereotaxis, Inc.
Semler Scientific, Inc.
Clearpoint Neuro, Inc.
TELA Bio, Inc.
Harvard Bioscience, Inc.
Jin Medical International Ltd.

Why is Hyperfine, Inc. ?

1
Poor Management Efficiency with a low ROE of 0%
  • The company has reported losses. Due to this company has reported negative ROE
2
With a growth in Net Profit of 45.86%, the company declared Very Positive results in Mar 26
  • The company has declared positive results for the last 2 consecutive quarters
  • OPERATING CASH FLOW(Y) Highest at USD -27.71 MM
  • NET SALES(HY) At USD 9.2 MM has Grown at 106.28%
  • NET PROFIT(HY) Higher at USD -15.76 MM
3
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 128.83%, its profits have risen by 11.6%
4
High Institutional Holdings at 24.83%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 4.34% over the previous quarter.
5
Market Beating Performance
  • The stock has generated a return of 128.83% in the last 1 year, much higher than market (S&P 500) returns of 25.41%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to Hyperfine, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Hyperfine, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Hyperfine, Inc.
128.83%
0.91
92.55%
S&P 500
25.41%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
70.86%
EBIT Growth (5y)
-303.86%
EBIT to Interest (avg)
-42.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.77
Sales to Capital Employed (avg)
0.24
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
24.83%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.65
EV to EBIT
-1.99
EV to EBITDA
-2.07
EV to Capital Employed
14.00
EV to Sales
5.38
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-703.99%
ROE (Latest)
-87.79%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company
OPERATING CASH FLOW(Y)

Highest at USD -27.71 MM

NET SALES(HY)

At USD 9.2 MM has Grown at 106.28%

NET PROFIT(HY)

Higher at USD -15.76 MM

RAW MATERIAL COST(Y)

Fallen by -23.26% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 1.36 times

DEBTORS TURNOVER RATIO(HY)

Highest at 2.35 times

-4What is not working for the Company
INTEREST(9M)

At USD 0.08 MM has Grown at inf%

Here's what is working for Hyperfine, Inc.

Net Sales
At USD 9.2 MM has Grown at 106.28%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD -27.71 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Net Profit
Higher at USD -15.76 MM
than preceding 12 month period ended Mar 2026
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

Inventory Turnover Ratio
Highest at 1.36 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 2.35 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost
Fallen by -23.26% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Hyperfine, Inc.

Interest
At USD 0.08 MM has Grown at inf%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)